SAN ANTONIO, March 10, 2026 – The academic and scientific landscape at The University of Texas at San Antonio (UT San Antonio) has undergone a remarkable transformation, positioning the institution as a formidable force in biomedical research and healthcare education. This evolution is evidenced by UT San Antonio’s impressive performance in the 2025 Blue Ridge Institute for Medical Research rankings, reflecting a new era of integrated scientific excellence and innovation.
In its debut appearance as a unified institution, UT San Antonio climbed five places to secure the 64th spot out of 2,702 U.S. institutions receiving funding from the National Institutes of Health (NIH). This places the university within the top 2.3% nationally and is anchored by a substantial $147 million in NIH research funding. Such a milestone underscores the strengthening synergy between research, clinical care, and education brought about by the recent institutional merger.
The Blue Ridge Institute rankings serve as a critical barometer of biomedical research prowess, incorporating comprehensive NIH funding data that are a direct reflection of peer-reviewed scientific merit and impact. UT San Antonio’s ascension in these rankings exemplifies its expanded research capabilities, robust infrastructure, and strategic collaborations that foster cutting-edge biomedical discoveries with meaningful health outcomes.
Francisco G. Cigarroa, MD, the senior executive vice president for health affairs and health system, emphasizes that this achievement marks a decisive moment in UT San Antonio’s trajectory. The elevated standing conveys the collective strength of the faculty and the benefits of an integrated academic health center capable of pioneering innovative biomedical science that advances human health on a regional and national scale.
The Joe R. and Teresa Lozano Long School of Medicine, a centerpiece of UT San Antonio’s health sciences enterprise, stands out with an impressive national rank of 50, supported by over $124 million in NIH funding. This funding fosters transformative research across a spectrum of critical biomedical domains, including cancer biology, neuroscience, infectious diseases, and aging, supporting breakthroughs that could reframe therapeutic paradigms.
Departments within the Long School of Medicine further highlight this vigorous research activity. With internal medicine securing over $25 million, microbiology, immunology, and molecular genetics contributing upwards of $16 million, biochemistry and structural biology surpassing $15 million, and pharmacology garnering $12.6 million, the faculty pushes the frontiers of biomedical understanding through multidisciplinary approaches and innovative methodologies.
The School of Dentistry has also made a significant leap, entering the prestigious ranks of the top 10 dental schools nationwide at number 9. Garnering nearly $9.8 million in NIH support, the school is pioneering advanced oral health research that intricately ties oral health innovations to systemic health improvements, illustrating the institution’s commitment to holistic healthcare excellence.
At the nexus of population health and scientific inquiry, the Kate Marmion School of Public Health is ranked 36th with NIH funding exceeding $6.7 million. This school’s research portfolio focuses on epidemiological and community-based studies designed to address pressing public health challenges, with implications for disease prevention, health policy formation, and scalable community health interventions.
Complementing this research ecosystem, the College of Sciences received nearly $5.8 million, reinforcing its central role in fundamental scientific discovery and educational mentorship. This investment supports broad-based research activities and cultivates the next generation of scientists, enabling a research environment that fuels upward social mobility through scientific and academic achievement.
UT San Antonio’s School of Nursing, ranked 73rd nationally, continues to expand its research footprint with more than $243,000 in NIH funding. Focused on evidence-based patient care improvements and health systems strengthening, nursing research here addresses critical clinical challenges and supports innovation in healthcare delivery that benefits diverse communities across Texas and beyond.
The 2025 Blue Ridge rankings vividly illustrate the power and promise of a unified UT San Antonio, drawing strength from its diverse schools of medicine, dentistry, nursing, public health, and science. This comprehensive integration amplifies research productivity and clinical impact, enabling multidisciplinary collaborations that harness the full potential of NIH-supported scientific exploration.
As UT San Antonio continues to broaden its research and clinical enterprises, its enhanced NIH funding performance foreshadows an era of robust national competitiveness. By fostering an environment where discovery, innovation, and translational medicine converge, the university promises to be a leading contributor to breakthroughs that shape biomedical science and improve health outcomes for populations well beyond South Texas.
The Blue Ridge Institute for Medical Research, a respected nonprofit entity, has long provided the scientific community and public with objective, data-driven insights into NIH funding trends. Its annual compendiums serve as a trusted metric of institutional scientific strength, reflecting the rigorous peer-review and meritocracy at the heart of NIH grant allocations. The 2025 data underpinning this year’s rankings reveal NIH’s commitment to funding excellence across a broad swath of biomedical research domains.
In fiscal 2025, the NIH allocated approximately $36.8 billion in research grants and contracts, distributed across more than 42,000 principal investigators. Within this funding landscape, schools of medicine received a commanding share—$19.3 billion or 52%—underscoring the centrality of medical research institutions in advancing health knowledge and therapeutic innovation nationwide.
UT San Antonio’s rising profile in the NIH funding arena is emblematic of a larger shift toward integrated health sciences research ecosystems. By aligning clinical expertise, scientific inquiry, and educational excellence under a unified institutional framework, the university is creating a dynamic blueprint for tackling complex biomedical challenges that demand innovative, interdisciplinary solutions.
This momentum heralds a future wherein UT San Antonio will not only sustain but accelerate its contributions to the national biomedical research enterprise. Through strategic investments in faculty, infrastructure, and translational science, the institution is poised to generate discoveries with profound implications for disease understanding, treatment, and prevention—impacting local communities and advancing global health.
Subject of Research:
Biomedical research and NIH funding performance at The University of Texas at San Antonio, including medical, dental, public health, nursing, and scientific disciplines.
Article Title:
UT San Antonio Emerges as a National Biomedical Research Leader in 2025 Blue Ridge NIH Funding Rankings
News Publication Date:
March 10, 2026
Web References:
– https://www.utsa.edu/
– https://uthscsa.edu/medicine/
– https://uthscsa.edu/dental/
– https://uthscsa.edu/public-health/
– https://uthscsa.edu/nursing/
– https://www.uthscsa.edu/
Keywords:
NIH funding, biomedical research, UT San Antonio, Blue Ridge Institute, medical research, dentistry research, public health, nursing research, scientific impact, academic health center
